Islam Zarmina, Mohanan Parvathy, Bilal Wajeeha, Hashmi Taleen, Rahmat Zainab, Abdi Ikran, Riaz Mehr Muhammad Adeel, Essar Mohammad Yasir
Faculty of Medicine, Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan.
Medical University Sofia, Sofia, Bulgaria.
Infect Drug Resist. 2022 Feb 2;15:367-371. doi: 10.2147/IDR.S347571. eCollection 2022.
Pakistan is currently facing two outbreaks, dengue and COVID-19; both have strained its healthcare system resulting in multiple concerns including the co-diagnosis of two. Due to poor healthcare capacity, low vaccination rate, increasing COVID-19 variants, socioeconomic disparities, and misinformation, it is inevitable that implications will prove to be damaging to both healthcare workers and civilians. Among these challenges, it is important to note the need for stronger epidemiological surveillance for both COVID-19 and dengue and the implementation of public health measures without endangering sources of livelihood. To sustain this, cooperation between WHO and Pakistan's government must continue through smart lockdowns, dengue awareness campaigns, and double laboratory procedures.
巴基斯坦目前正面临登革热和新冠肺炎两大疫情;两者都使该国医疗系统不堪重负,引发了包括两种疾病共同诊断在内的诸多问题。由于医疗能力薄弱、疫苗接种率低、新冠病毒变种不断增加、社会经济差距以及错误信息的传播,其影响不可避免地会对医护人员和平民造成损害。在这些挑战中,必须注意到加强对新冠肺炎和登革热的流行病学监测以及在不危及生计来源的情况下实施公共卫生措施的必要性。为维持这种状况,世卫组织与巴基斯坦政府之间的合作必须通过明智的封锁、登革热宣传活动和双重实验室程序继续下去。